| GC33543-5mg |
|
1984862-48-7 |
|
0 |
C14H20ClN5O4 |
|
|
|
| GC33543-1mg |
|
1984862-48-7 |
|
0 |
C14H20ClN5O4 |
|
|
|
| GC33543-10mM(1mLinDMSO) |
|
1984862-48-7 |
|
0 |
C14H20ClN5O4 |
|
|
|
| GC33542-1g |
|
938-73-8 |
2-Ethoxybenzamide (Ethenzamide)
|
0 |
C9H11NO2 |
|
|
|
| GC33542-10mM(1mLinDMSO) |
|
938-73-8 |
2-Ethoxybenzamide (Ethenzamide)
|
0 |
C9H11NO2 |
|
|
|
| GC33541-100mg |
|
162411-29-2 |
Heptamethine cyanine dye-1 (ADS 815EI)
|
0 |
C42H44ClIN2 |
|
|
|
| GC33541-50mg |
|
162411-29-2 |
Heptamethine cyanine dye-1 (ADS 815EI)
|
0 |
C42H44ClIN2 |
|
|
|
| GC33541-25mg |
|
162411-29-2 |
Heptamethine cyanine dye-1 (ADS 815EI)
|
0 |
C42H44ClIN2 |
|
|
|
| GC33541-10mg |
|
162411-29-2 |
Heptamethine cyanine dye-1 (ADS 815EI)
|
0 |
C42H44ClIN2 |
|
|
|
| GC33541-5mg |
|
162411-29-2 |
Heptamethine cyanine dye-1 (ADS 815EI)
|
0 |
C42H44ClIN2 |
|
|
|
| GC33540-10mg |
|
364071-16-9 |
OT-R antagonist 2 (Oxytocin receptor antagonist 2)
|
0 |
C28H29N3O4 |
|
|
|
| GC33540-5mg |
|
364071-16-9 |
OT-R antagonist 2 (Oxytocin receptor antagonist 2)
|
0 |
C28H29N3O4 |
|
|
|
| GC33540-1mg |
|
364071-16-9 |
OT-R antagonist 2 (Oxytocin receptor antagonist 2)
|
0 |
C28H29N3O4 |
|
|
|
| GC33540-10mM(1mLinDMSO) |
|
364071-16-9 |
OT-R antagonist 2 (Oxytocin receptor antagonist 2)
|
0 |
C28H29N3O4 |
|
|
|
| GC33539-1g |
|
1662-01-7 |
|
0 |
C24H16N2 |
|
|
|
| GC33539-500mg |
|
1662-01-7 |
|
0 |
C24H16N2 |
|
|
|
| GC33539-10mM(1mLinDMSO) |
|
1662-01-7 |
|
0 |
C24H16N2 |
|
|
|
| GC33538-100mg |
|
102-76-1 |
Triacetin (Glyceryl triacetate)
|
0 |
C9H14O6 |
|
|
|
| GC33538-10mM(1mLinDMSO) |
|
102-76-1 |
Triacetin (Glyceryl triacetate)
|
0 |
C9H14O6 |
|
|
|
| GC33537-5mg |
|
118525-36-3 |
|
0 |
C32H38O14 |
|
|
|
